- Medical Devices
- Wednesday, 07 Apr 2021
More than US$ 18,085.96 million Revenues Projected to be Accounted by Atrial Fibrillation Market by End of 2027
According to The Insight Partners market research study of 'Atrial Fibrillation Market to 2027 – Global Analysis and Forecasts by Treatment Type and End User'. The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving market along with those that act as hindrances.
The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories
Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00003531/
Company Profiles
- Boston Scientific Corporation
- Medtronic
- AtriCure, Inc
- Biosense Webster, Inc.
- BOEHRINGER INGELHEIM GMBH
- CardioFocus
- Abbott
- Sanofi
- Biotronik Inc.
- Bristol-Myers Squibb Company
The Atrial Fibrillation Market for is expected to grow, owing to factors such as increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Moreover, growth opportunities in the developing nations are likely to have a positive impact on the growth of the market in coming years.
Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.
End User Insights
The end-user segment market is segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratories. The hospitals segment held the largest share of the market in 2019. In addition, the segment is also estimated to register the highest CAGR in the market during the forecast period. The hospital segment held the largest share as hospitals are primary point of care for most of the population across the globe and the treatment procedures for atrial fibrillation are easily carried out in the hospitals due to availability of the experienced cardiologists, experts and assisting staffs.
Strategic Insights
Merger & acquisition strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to enhance its product portfolio.
The market players operating in the atrial fibrillation marketadopt the strategy of expansion and investment in research and development to enlarge customer base across the world, which also permits the players to maintain their brand name globally.
Global Atrial Fibrillation Market – ByTreatment Type
- Non – pharmacological
- MAZE Surgery
- Catheter Ablation
- Electric Cardioversion
- Pharmacological
- Anti-arrhythmic Drugs
- Anti-coagulant Drugs
Global Atrial fibrillation Market– By End User
- Hospitals
- Ambulatory Surgical Centers,
- Cardiac Catheterization Laboratories
Atrial fibrillation Market– By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00003531/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
North America Automated Compounding Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Gravimetric Automated Compounding Systems Volumetric Automated Compounding Systems); By End User (Hospitals and Pathology Laboratories,Blood Banks,Others);and Geography
Apr 12, 2021
Europe Medical Devices Additives Manufacturing Market Key Players, Industry Overview and Forecast Analysis - 3D Systems, GE Additives, Materialise NV, Renishaw plc.
Dec 01, 2020
Neuromodulation Market Is Booming across to reach CAGR of 10.3%during 2020–2027 with NEVRO CORP., Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, Magstim
Mar 26, 2021
Asia Pacific Diabetes Care Devices Market with (Covid-19) Impact Analysis: Forecast to Show Spurring Growth by 2020-2027
Aug 08, 2020
Surgical Smoke Aspirators Market Skyrocketing CAGR by 2027 Worldwide with Medtronic, EPSIMED, MDxHealth, Buffalo Filter LLC, Virtual Scientific, Meyer-Haake GmbH, KARL STORZ SE & Co. KG, Megadyne S.P.A
Mar 23, 2021
Neurostimulation Devices Market is expected to reach US$ 11,825.95 million by 2030
Sep 28, 2023
Vaccines Market Share, Trends, Opportunities & Forecast 2027
Jan 08, 2021